Related Experiment Videos
Increased nuclear proto-oncogene expression in hypertrophic cardiomyopathy
1Cardiology Department, Philipps-University of Marburg, Germany.
Cardioscience
|March 1, 1993
Summary
Nuclear proto-oncogenes like c-fos, c-jun, and c-myc are activated in patients with hypertrophic cardiomyopathy. This finding suggests their potential role in the disease, though triggers remain unclear.
Area of Science:
- Cardiology
- Molecular Biology
- Oncology
Background:
- Hypertrophic cardiomyopathy involves unexplained left ventricle hypertrophy, particularly the interventricular septum.
- While genetic mutations are known, the pathways causing myocyte hypertrophy are unclear.
Purpose of the Study:
- To investigate the role of nuclear proto-oncogene expression in hypertrophic cardiomyopathy.
- To determine if proto-oncogenes like c-myc, c-fos, and c-jun are activated in affected individuals.
Main Methods:
- Endomyocardial biopsies from 13 hypertrophic cardiomyopathy patients were analyzed.
- Monoclonal antibodies against c-myc, c-fos, and c-jun were used to detect protein expression.
Main Results:
- Nuclear proto-oncogenes c-fos, c-jun, and c-myc were expressed in 53%, 60%, and 50% of patients, respectively.
- Control biopsies showed minimal c-myc expression (10%) and no detectable c-fos or c-jun.
Conclusions:
- Nuclear proto-oncogenes are significantly induced in patients with hypertrophic cardiomyopathy.
- The study highlights a potential molecular mechanism in hypertrophic cardiomyopathy, but triggers require further investigation.